A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy

ClinicalTrials.gov ID: NCT07918989

Public ClinicalTrials.gov record NCT07918989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OPTimal Intervention for the Prevention of Radiation Dermatitis During Breast Cancer Post-Mastectomy Radiotherapy (OPTIC): A Parallel, Three-Arm, Phase II Open-Label Randomized Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out which of three standard skin care approaches works best to prevent a skin reaction called radiation dermatitis (redness, irritation, or breakdown of the skin) in people receiving radiation therapy after mastectomy.

Study identification

NCT ID: NCT07918989
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Enrollment: 138 participants

Conditions and interventions

Conditions

Interventions

Drug · Device · Dietary Supplement + 1 more

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 30, 2026 (Actual)
Primary completion: Oct 30, 2028 (Estimated)
Completion: Oct 30, 2028 (Estimated)
Last update posted: Nov 5, 2026

2026 – 2028

United States locations

U.S. sites: 7
U.S. states: 2
U.S. cities: 7

Facility	City	State	ZIP	Site status
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)	Basking Ridge	New Jersey	07920	Recruiting
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	New Jersey	07748	Recruiting
Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale	New Jersey	07645	Recruiting
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities )	Commack	New York	11725	Recruiting
Memorial Sloan Kettering Westchester (All Protocol Activities)	Harrison	New York	10604	Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activites)	New York	New York	10065	Recruiting
Memorial Sloan Kettering Nassau (All protocol activities)	Rockville Centre	New York	11553	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07918989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 5, 2026 · Synced Nov 6, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07918989 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →